Journal of Clinical Lipidology

Title Publication Date Language Citations
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report2015/03/01English544
Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial2015/11/01English344
Understanding Statin Use in America and Gaps in Patient Education (USAGE): An internet-based survey of 10,138 current and former statin users2012/05/01English334
National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summary2014/09/01English331
Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients2011/06/01English330
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 22015/11/01English320
An assessment by the Statin Muscle Safety Task Force: 2014 update2014/05/01English316
LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study—Implications for LDL management2007/12/01English296
Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid Association2013/07/01English292
Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association2019/05/01English288
Clinical implications of discordance between low-density lipoprotein cholesterol and particle number2011/03/01English259
Familial Hypercholesterolemias: Prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia2011/06/01English249
High-density lipoproteins: A consensus statement from the National Lipid Association2013/09/01English239
Hypolipidemia is associated with the severity of COVID-192020/05/01English226
“Atherogenic index of plasma” (log10 triglyceride/high-density lipoprotein−cholesterol) predicts high blood pressure, diabetes, and vascular events2010/03/01English222
An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report2014/01/01English221
Review of current evidence and clinical recommendations on the effects of low-carbohydrate and very-low-carbohydrate (including ketogenic) diets for the management of body weight and other cardiometabolic risk factors: A scientific statement from the National Lipid Association Nutrition and Lifestyle Task Force2019/09/01English209
Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists2011/09/01English200
Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients2011/05/01English199
Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: A review2012/01/01English195
Predictors of statin adherence, switching, and discontinuation in the USAGE survey: Understanding the use of statins in America and gaps in patient education2013/09/01English181
A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality2016/05/01English180
Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial2014/01/01English177
Prevalence of lipid abnormalities in the United States: The National Health and Nutrition Examination Survey 2003–20062012/07/01English173
Fatty acids in cardiovascular health and disease: A comprehensive update2012/05/01English169
An assessment by the Statin Liver Safety Task Force: 2014 update2014/05/01English148
A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: The ECLIPSE (Epanova® compared to Lovaza® in a pharmacokinetic single-dose evaluation) study2012/11/01English142
Severe hypertriglyceridemia is primarily polygenic2019/01/01English132
Cascade screening based on genetic testing is cost-effective: Evidence for the implementation of models of care for familial hypercholesterolemia2014/07/01English131
The importance of non–HDL cholesterol reporting in lipid management2008/08/01English130